Conference Proceedings
Changes in plasma lipid species following pravastatin treatment predict cardiovascular outcomes and represent a measure of the relative risk reduction in secondary prevention
P Meikle, KS Jayawardana, PA Mundra, PJ Nestel, EH Barnes, A Kirby, P Thompson, DR Sullivan, ZH Alshehry, K Huynh, C Giles, IC Marschner, BA Kingwell, J Simes, AM Tonkin
EUROPEAN HEART JOURNAL | OXFORD UNIV PRESS | Published : 2018
Grants
Awarded by National Health and Medical Research Council of Australia
Funding Acknowledgements
This work was funded by the National Health and Medical Research Council of Australia (grant number 1029754).